Psoriatic arthritis: prevalence, diagnosis, and review of therapy for the dermatologist
- 1 October 2004
- journal article
- research article
- Published by Elsevier in Dermatologic Clinics
- Vol. 22 (4) , 477-486
- https://doi.org/10.1016/s0733-8635(03)00127-x
Abstract
No abstract availableKeywords
This publication has 60 references indexed in Scilit:
- Efficacy of infliximab in resistant psoriatic arthritisArthritis Care & Research, 2003
- Etanercept versus methotrexate in patients with early rheumatoid arthritis: Two‐year radiographic and clinical outcomesArthritis & Rheumatism, 2002
- Tuberculosis Associated with Infliximab, a Tumor Necrosis Factor α–Neutralizing AgentNew England Journal of Medicine, 2001
- Subclinical Joint Involvement in Psoriasis: Magnetic Resonance Imaging and X-ray FindingsActa Dermato-Venereologica, 1998
- Significance of antibodies to streptococcal M protein in psoriatic arthritis and their association with HLA-A*0207Tissue Antigens, 1996
- Anti-inflammatory efficacy of low-dose cyclosporin A in psoriatic arthritis. A prospective multicentre studyBritish Journal of Dermatology, 1996
- American college of rheumatology preliminary definition of improvement in rheumatoid arthritisArthritis & Rheumatism, 1995
- The role of hla antigens as indicators of disease progression in psoriatic arthritisArthritis & Rheumatism, 1995
- A MULTICENTRE DOUBLE-BLIND COMPARISON OF AURANOFIN, INTRAMUSCULAR GOLD THIOMALATE AND PLACEBO IN PATIENTS WITH PSORIATIC ARTHRITISRheumatology, 1990
- A comparative pilot study of azapropazone and indomethacin in the treatment of psoriatic arthritis and Reiter's diseaseCurrent Medical Research and Opinion, 1976